Literature DB >> 30783261

Cochrane Eyes and Vision: a perspective introducing Cochrane Corner in Eye.

Jennifer Evans1, Tianjing Li2, Gianni Virgili3, Richard Wormald4.   

Abstract

In 1972, Archie Cochrane wrote "It is surely a great criticism of our profession that we have not organised a critical summary, by specialty or subspecialty, adapted periodically, of all relevant randomised controlled trials". The Cochrane Collaboration arose in response to Archie Cochrane's challenge. Cochrane Eyes and Vision aims to prepare and promote access to systematic reviews of interventions for preventing or treating eye conditions and/or visual impairment, and helping people adjust to visual impairment or blindness. To identify all relevant randomised controlled trials, Cochrane Eyes and Vision has a team of information specialists who develop search strategies to identify studies for inclusion in Cochrane reviews. Since 1997 we have published 266 protocols, 193 new reviews and 158 updated reviews. The majority of these are reviews of intervention effectiveness; three reviews are diagnostic test accuracy reviews. Overall 18% of reviews contain no trials, highlighting a potential evidence gap. We provide training, education and guidance to systematic review authors and work with clinical and patient partners to prioritise and disseminate reviews. In addition, Cochrane Eyes and Vision US satellite carries out critical methodologic research addressing topics relevant to producing high-quality reviews. We are partnering with the journal Eye to publish commentaries on selected Cochrane systematic review findings. This partnership will allow us to make high-quality evidence available to ophthalmologists and other practitioners, researchers, policy makers and patients.

Entities:  

Mesh:

Year:  2019        PMID: 30783261      PMCID: PMC6707294          DOI: 10.1038/s41433-019-0357-7

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  32 in total

1.  User testing and stakeholder feedback contributed to the development of understandable and useful Summary of Findings tables for Cochrane reviews.

Authors:  Sarah E Rosenbaum; Claire Glenton; Hilde Kari Nylund; Andrew D Oxman
Journal:  J Clin Epidemiol       Date:  2010-06       Impact factor: 6.437

Review 2.  Reducing inequity of cataract blindness and vision impairment is a global priority, but where is the evidence?

Authors:  Jacqueline Ramke; Jennifer R Evans; Clare E Gilbert
Journal:  Br J Ophthalmol       Date:  2018-05-29       Impact factor: 4.638

3.  The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.

Authors:  John P A Ioannidis
Journal:  Milbank Q       Date:  2016-09       Impact factor: 4.911

Review 4.  The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care.

Authors:  I Chalmers
Journal:  Ann N Y Acad Sci       Date:  1993-12-31       Impact factor: 5.691

5.  Research Questions and Outcomes Prioritized by Patients With Dry Eye.

Authors:  Ian J Saldanha; Rebecca Petris; Genie Han; Kay Dickersin; Esen K Akpek
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

6.  Reporting Weaknesses in Conference Abstracts of Diagnostic Accuracy Studies in Ophthalmology.

Authors:  Daniël A Korevaar; Jérémie F Cohen; Maurice W J de Ronde; Gianni Virgili; Kay Dickersin; Patrick M M Bossuyt
Journal:  JAMA Ophthalmol       Date:  2015-12       Impact factor: 7.389

7.  Assessment of the Incorporation of Patient-Centric Outcomes in Studies of Minimally Invasive Glaucoma Surgical Devices.

Authors:  Jimmy T Le; Shilpa Viswanathan; Michelle E Tarver; Malvina Eydelman; Tianjing Li
Journal:  JAMA Ophthalmol       Date:  2016-09-01       Impact factor: 7.389

8.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

9.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Authors:  Jonathan Ac Sterne; Miguel A Hernán; Barnaby C Reeves; Jelena Savović; Nancy D Berkman; Meera Viswanathan; David Henry; Douglas G Altman; Mohammed T Ansari; Isabelle Boutron; James R Carpenter; An-Wen Chan; Rachel Churchill; Jonathan J Deeks; Asbjørn Hróbjartsson; Jamie Kirkham; Peter Jüni; Yoon K Loke; Theresa D Pigott; Craig R Ramsay; Deborah Regidor; Hannah R Rothstein; Lakhbir Sandhu; Pasqualina L Santaguida; Holger J Schünemann; Beverly Shea; Ian Shrier; Peter Tugwell; Lucy Turner; Jeffrey C Valentine; Hugh Waddington; Elizabeth Waters; George A Wells; Penny F Whiting; Julian Pt Higgins
Journal:  BMJ       Date:  2016-10-12

10.  Identifying reports of randomized controlled trials (RCTs) via a hybrid machine learning and crowdsourcing approach.

Authors:  Byron C Wallace; Anna Noel-Storr; Iain J Marshall; Aaron M Cohen; Neil R Smalheiser; James Thomas
Journal:  J Am Med Inform Assoc       Date:  2017-11-01       Impact factor: 4.497

View more
  1 in total

1.  Efficacy and safety of manual acupuncture for the treatment of upper limb motor dysfunction after stroke: Protocol for a systematic review and meta-analysis.

Authors:  Di Cao; Xiaolin Zhang; Mingjun Liu; Qiguang Yang; Shuhong Gu; Tianjiao Gao; Lin Cong; Dehui Ma; Hongju Lin; Shaotao Chen
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.